key: cord-0704841-gvai1kjg authors: Fonseca, Vagner; de Jesus, Ronaldo; Adelino, Talita; Reis, Alexandre Barbosa; de Souza, Breno Bernardes; Ribeiro, Adriana Aparecida; Guimarães, Natália Rocha; Livorati, Miriam Teresinha Furlam Prado; Neto, Daniel Ferreira de Lima; Kato, Rodrigo Bentes; Portela, Layssa Miranda de Oliveira; Dutra, Leonardo Hermes; Freitas, Carla; de Abreu, André Luiz; Filizzola, Eduardo Regis Melo; de Medeiros, Arnaldo Correia; Iani, Felipe Campos de Melo; Carvalho, Glauco; Lourenço, José; de Oliveira, Tulio; Alcantara, Luiz Carlos Junior; Giovanetti, Marta title: Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil date: 2021-05-21 journal: J Infect DOI: 10.1016/j.jinf.2021.05.014 sha: 067ad7d3165b6208f369a0c0c87743bd9d3648a5 doc_id: 704841 cord_uid: gvai1kjg nan Vagner Fonseca 1,2,3 *+ , Ronaldo de Jesus 1,2 + , Talita Adelino 2,4 + , Alexandre Barbosa Reis 5 and here we report the first confirmed case of SARS-CoV-2 reinfection of a 29-year-old male, medical doctor, from Minas Gerais state, Southeast Brazil. The duration of acquired immunity conferred by infection with SARS-CoV-2 is still poorly understood and recently released data suggest that having COVID-19 may not protect against getting infected again with some of the new variants, evoking the nightmare of a never-ending pandemic. -Brazil, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected more than 12 million people and to date, has caused approximately 300 thousand deaths in Brazil 2 . Infection with SARS-CoV-2 leads to detectable, short-lasting, IgG responses 3,4 likely to provide protection to reinfection. Nonetheless, susceptibility of previously infected individuals to reinfection, due to the circulation of different SARS-CoV-2 variants and lineages [5] [6] [7] , is now starting to be considered a growing concern. Here, we present the first confirmed case of SARS-CoV-2 reinfection in Minas Gerais state, presenting two distinct COVID-19 illnesses from genetically distinct SARS-CoV-2 variants, including the emerging B.1.2 lineage in Brazil. Identifying cases of SARS-CoV-2 reinfection is essential to better understand the course of the COVID-19 pandemic, to monitor the evolution of population herdimmunity, and to guide strategies for vaccine development. A 29-year-old male, medical doctor, resident in Sabará, Minas Gerais state, southeast Brazil, with no comorbidities, presented two clinical episodes of SARS-CoV-2 infection separated by a 225-day interval (Figure 1 panel A) . In the first episode on May 21st, 2020 the patient presented fever, myalgia, cough, sore throat, and diarrhea for approximatively 10 days (Figure 1 panel A) . Two months after testing positive by RT-PCR in the first episode, an IgG test against S1 protein by chemiluminescence, was performed and showed a positive result (index value: 5.07 on 07/08/2020), followed by a negative IgG assay on Mid-December 2020. T ' J 4 g R Janeiro, when a second nasopharyngeal swab (on January 06th, 2021) (Figure 1 panel A) was obtained and presented a positive result for SARS-CoV-2 infection by re-al-time RT-PCR testing. Viral RNA was extracted from nasopharyngeal swabs and tested for SARS-CoV-2 using the protocol established by the Center for Disease Control and Prevention that targets the Nucleocapsid gene (CDC, Atlanta) 8 . On both occasions, results of RT-PCR tests targeting 2 genes (N1 and N2) were positive for SARS-CoV-2. Antibody testing (IgG) after the first and the second episode was performed by Cycle threshold values (Cts) of N1, and N2 targets were 15.7, and 18.9 in the first episode and 17.6, and 19.6 in the second episode. In early February 2021, a second positive IgG assay was also detected (index value: 7,58) (Figure 1 panel A) . Laboratories to accelerate knowledge building and contribute to surveillance and outbreak response. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers Coronavírus Brasil Seasonal coronavirus protective immunity is short-lasting Understanding protection from SARS-CoV-2 by studying reinfection Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677 Center for Disease Control and Prevention. 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel Multiple Sequence Alignment Software Version 7: improvements in performance and usability IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies Figure 1. Genomic characterization of a COVID-19 reinfection case in Minas Gerais state A) Timeline of symptom onset, molecular diagnosis, and sequencing of specimens B) ML tree including the newly SARS-CoV-2 genomes (EPI_ISL_1182550 and EPI_ISL_1182549) recovered from a 29-year-old male resident in Sabará, Minas Gerais state, Southeast Brazil, with n=3852 representative full-length viral genomes available on GISAID We are grateful to all participants in this study and special the Mater Dei Hospital for their work in Newly generated SARS-CoV-2 sequences have been deposited in GISAID under accession numbers EPI_ISL_1182550 and EPI_ISL_1182549. The authors declare no conflict of interest.